Related Topics: Government Policies & Initiatives, Public Health
Union Cabinet chaired by the PM Narendra Modi has been apprised of the Progress under National Health Mission (NHM) and Decisions of the Empowered Programme Committee and Mission Steering Group of the NHM.
- There has been acceleration in decline of Maternal Mortality Ratio (MMR), Under Five Mortality Rate (U5MR) and the IMR since the launch of the NRHM/NHM.
- At the current rate of decline, India should able to reach its SDG target (MMR-70, U5MR-25) much before the due year. 2030.
- India was the biggest success story amongst Malaria endemic countries in the World, in bringing down the Malaria cases and deaths which have declined by 49.09% and 50.52% in 2013 respectively compared to 2017.
- Revised National Tuberculosis Control Programme (RNTCP) has been significantly strengthened and intensified.
- Newer drug regimen of Bedaquiline and Delaminide and nutrition support to all the TB patients for the duration of the treatment has been rolled throughout the country.
- Amongst the new vaccines, Tetanus and adult Diphtheria (Td) vaccine replaced Tetanus Toxoid (TT) vaccine under universal immunization programme in 2018 to ensure Diphtheria immunity among adults.
- In 2018, Measles-Rubella (MR) vaccination drive was conducted in 17 additional States, thereby covering 30.50 Crores children till March 2019.
- During 2018-19, Rotavirus vaccine (RVV) was introduced in additional two States. Till today, all the States/UTs are covered with RVV.
- The routine and recurring incentives of ASHAs got increased from 1000 per month to 2000 per month.
- ASHAs and ASHA Facilitators were provided the cover of Pradhan Mantri Jevan Jyoti Beema Yojna (Premium of Rs. 330 contributed by Gol) and Pradhan Mantri Suraksha Beema Yojna (Premium of Rs.12 contributed by Gol).
- Anaemia Mukt Bharat (AMB) Abhiyaan was launched under POSHAN Abhiyaan in April 2018.
- Home Based Care for Young Child (HBYC) programme was introduced under POSHAN Abhiyaan.
- National Viral Hepatitis Control Programme was approved for prevention, management and treatment of Hepatitis to A, B, C and E and rollout was initiated. This would benefit an estimated 5 crore patients of Hepatitis.
- The scheme for awarding States/UTs/Districts for achieving disease free status in TB/Leprosy/Malaria/Kala-Azar/Lymphatic-Filariasis/Cataract was approved.